- FDA+ roundup: FDA’s neuroscience deputy departs amid ongoing Aduhelm investigations; Califf on the ropes?
- First Platform for Massively Multiplexed Single-Cell In Situ Spatial Genomics Now Broadly Available to U.S. Market
- Mass General Brigham lays out five-year, $8.3B capital plan
- CCC to Host Virtual Town Hall, “Understanding the New UKRI Open Access Policy”
- CANbridge Pharmaceuticals CAN108 New Drug Application (NDA) for Alagille Syndrome Accepted by China’s National Medical Products Administration
- Eisai takes baton from Biogen as next Alzheimer’s prospect follows in Aduhelm’s footprints
- Fierce JPM Week: Confidence is high for Eli Lilly CEO Ricks in showdown with Biogen’s Aduhelm
- Sema4 shells out $623M to scoop up a leading diagnostics player and its trove of data
- MarketingRx roundup: Aduhelm can’t get traction with docs; Pfizer presses vaccine effort during NFL playoffs
- Amgen Ventures Invests in TileDB to Advance Their Universal Database
Copyright © 2022 Biotech Networks, LLC
